Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ALR

Alere (ALR) Stock Price, News & Analysis

Alere logo

About Alere Stock (NYSE:ALR)

Key Stats

Today's Range
$1.32
$1.32
50-Day Range
N/A
52-Week Range
$34.41
$51.00
Volume
N/A
Average Volume
40,839 shs
Market Capitalization
$43.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alere and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALR Stock News Headlines

Alro SA ALR
Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
ABP Acquisition to Acquire AlerisLife for $1.31 Per Share
AlerisLife Inc. Announces Third Quarter 2022 Results
See More Headlines

ALR Stock Analysis - Frequently Asked Questions

Alere Inc. (NYSE:ALR) released its earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by $0.35. Alere's revenue was down 3.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alere investors own include Morgan Stanley (MS), HeartBeam (BEAT), Abbott Laboratories (ABT), Edwards Lifesciences (EW), FireEye (FEYE), Twitter (TWTR) and AEGR (AEGR).

Company Calendar

Last Earnings
11/04/2016
Today
9/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Skilled nursing care facilities
Sub-Industry
Health Care Supplies
Current Symbol
NYSE:ALR
CIK
1145460
Employees
10,400
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
-5.34%
Pretax Margin
-5.29%
Return on Equity
-20.78%
Return on Assets
-9.02%

Debt

Debt-to-Equity Ratio
0.45
Current Ratio
1.58
Quick Ratio
1.58

Sales & Book Value

Annual Sales
$934.59 million
Price / Sales
0.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.72 per share
Price / Book
0.23

Miscellaneous

Outstanding Shares
32,610,000
Free Float
29,870,000
Market Cap
$43.05 million
Optionable
Optionable
Beta
0.85
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:ALR) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners